Avalanche Biotechnologies
- Biological Products, Except Diagnostic Substances
- Redwood City, California
Compensation history
Top executives at Avalanche Biotechnologies received an average of $2M per person in annual compensation from 2013 to 2023.
Average pay of disclosed executives at Avalanche Biotechnologies
By year
- 2022
LF$3MLaurent FischerPresident and Chief Executive OfficerSS$2MSetareh SeyedkazemiChief Development OfficerRB$1MRichard BeckmanChief Medical OfficerKS$1MKishor Peter SoparkarChief Operating OfficerJR$1MJohn RakowFormer Acting Chief Financial OfficerRD$636KRupert D'SouzaFormer Chief Financial OfficerLR$112KLinda RubinsteinChief Financial Officer- 2021
LF$9MLaurent FischerPresident and Chief Executive OfficerCD$4MChristopher DeRespinoFormer Chief Business Officer and Interim Chief Financial OfficerAT$3MAngela ThedingaFormer Chief Technology OfficerLP$3MLeone PattersonFormer President and Chief Financial OfficerKS$2MKishor Peter SoparkarChief Operating Officer and Chief Legal OfficerJC$2MJulie ClarkFormer Chief Medical OfficerBR$2MBrigit RileyChief Scientific OfficerRD$557KRupert D'SouzaChief Financial OfficerTL$501KThomas LeungFormer Chief Financial OfficerJT$65KJack ThriftFormer Interim Chief Financial Officer
Executives
We found 20 executives who work or worked at Avalanche Biotechnologies.
Laurent Fischer
Avalanche Biotechnologies
Chief Executive Officer
Linda Rubinstein
Avalanche Biotechnologies
Chief Financial Officer
Setareh Seyedkazemi
Avalanche Biotechnologies
Chief Development Officer
Kishor Soparkar
Avalanche Biotechnologies
Chief Operating Officer
Richard Beckman
Avalanche Biotechnologies
Chief Medical Officer
Rupert D'Souza
Avalanche Biotechnologies
Chief Financial Officer
John Rakow
Avalanche Biotechnologies
Chief Financial Officer
Leone Patterson
Avalanche Biotechnologies
Chief Financial Officer
News
About Avalanche Biotechnologies
- Industry classifications
- DivisionManufacturing
- Major groupChemicals And Allied Products
- Industry groupDrugs
- IndustryBiological Products, Except Diagnostic Substances
- Address100 Cardinal Way, Redwood City, California 94063
- Phone(650) 649-1004
- Fiscal year endDecember 31
- Former names
- Avalanche Biotechnologies, Inc.Until May 9, 2016
Source: SEC filings on May 2, 2024, April 25, 2023, April 26, 2022, April 26, 2017, and April 30, 2015.